Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease

Cytokine

Volumn 72, Issue 2, 2015, Pages 160-165

  Guan, Li juan ^a   Wang, Xuan ^a,b   Meng, Shuai ^b   Shi, Liang feng ^b   Jiang, Wen juan ^b   Xiao, Ling ^b   Shi, Xiao hong ^b   Xu, Jian ^b   Zhang, Jin an ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Autoimmune thyroid disease (AITD); Graves' disease (GD); Hashimoto's thyroiditis (HT); Interleukin 21 (IL 21); Interleukin 21 receptor (IL 21R)

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 21; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; LEUKOCYTE CULTURE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYROID CELL; UPREGULATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; THYROID GLAND; ULTRASTRUCTURE;

ADULT; FLOW CYTOMETRY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-4; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-21; RECOMBINANT PROTEINS; THYROID GLAND;

EID: 84922053653     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.11.005     Document Type: Article

References (25)

1. Heuer M., Aust G., Ode-Hakim S., Scherbaum W.A. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996, 6:97-106.
2. Phenekos C., Vryonidou A., Gritzapis A.D., Baxevanis C.N., Goula M., et al. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation 2004, 11:209-213.
3. Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C., et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408:57-63.
4. Asao H., Okuyama C., Kumaki S., Ishii N., Tsuchiya S., et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J Immunol 2001, 167:1-5.
5. Habib T., Senadheera S., Weinberg K., Kaushansky K. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 2002, 41:8725-8731.
6. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., et al. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
7. Rückert R., Bulfone-Paus S., Brandt K. Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin Exp Immunol 2008, 151:487-895.
8. Distler J.H., Jüngel A., Kowal-Bielecka O., Michel B.A., Gay R.E., et al. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis. Arthritis Rheum 2005, 52:856-864.
9. Liu Z., Yang L., Cui Y., Wang X., Guo C., et al. IL-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1133-1144.
10. Li J., Shen W., Kong K., Liu Z. Interleukin-21 induces T-cell activation and proinflammatory cytokine secretion in rheumatoid arthritis. Scand J Immunol 2006, 64:515-522.
11. Dolff S., Abdulahad W.H., Westra J., Doornbos-van der Meer B., Limburg P.C., et al. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2011, 13:R157.
12. Sawalha A.H., Kaufman K.M., Kelly J.A., Adler A.J., Aberle T., et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2007, 67:458-461.
13. Jüngel A., Distler J.H., Kurowska-Stolarska M., Seemayer C.A., Seibl R., et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:1468-1476.
14. Liu L., Xu Y., Wang J., Li H. Upregulated IL-21 and IL-21 receptor expression is involved in experimental autoimmune uveitis (EAU). Mol Vis 2009, 15:2938-2944.
15. Ueda M., Imada K., Imura A., Koga H., Hishizawa M., et al. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol 2005, 128:169-176.
16. Sutherland A.P., Van Belle T., Wurster A.L., Suto A., Michaud M., et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 2009, 58:1144-1155.
17. Jia H.Y., Zhang Z.G., Gu X.J., Guo T., Cui B., et al. Association between interleukin 21 and Graves' disease. Genet Mol Res 2011, 10:3338-3346.
18. Zhu C., Ma J., Liu Y., Tong J., Tian J., et al. Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab 2012, 97:943-950.
19. Onoda T., Rahman M., Nara H., Araki A., Makabe K., et al. Human CD4+ central and effector memory T cells produce IL-21: effect on cytokine-driven proliferation of CD4+ T cell subsets. Int Immunol 2007, 19:1191-1199.
20. Strengell M., Sareneva T., Foster D., Julkunen I., Matikainen S. IL-21 up-regulates the expression of genes associated with innate immunity and Th1 response. J Immunol 2002, 169:3600-3605.
21. Tzartos J.S., Craner M.J., Friese M.A., Jakobsen K.B., Newcombe J., et al. IL-21andIL-21receptorexpressioninlymphocytesandneuronsinmul-tiplesclerosisbrain. Am J Pathol 2011, 178:794-802.
22. Niedbala W., Cai B., Wei X., Patakas A., Leung B.P., et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008, 67:1474-1479.
23. Sasaoka T., Ito M., Yamashita J., Nakajima K., Tanaka I., et al. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells. Am J Physiol Gastrointest Liver Physiol 2011, 300:568-576.
24. Li F., Yang P., Liu X., Wang C., Hou S., et al. Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease. Arch Ophthalmol 2010, 128:1449-1454.
25. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007, 448:484-487.